WebFlecainide is an antiarrhythmic medication. It treats paroxysmal supraventricular tachycardia (PSVT), a potentially life-threatening irregular heartbeat. The prescription drug can slow or block electrical signals in the heart and stabilize the heartbeat. WebSep 26, 2024 · Primary specific aim of this pilot trial is to determine whether Flecainide administration is associated with a significant reduction of number of ventricular ectopic beats (VEBs) in ARVC patients with implantable cardioverter-defibrillator (ICD). Secondary specific aims are:
Flecainide challenge test: Predictors of unmasking of type …
WebAbstract. Objectives: The purpose of this study was to compare the effect of intravenous flecainide and ajmaline with respect to their ability to induce or accentuate the typical ECG pattern of Brugada syndrome. Background: Brugada syndrome is associated with a high incidence of sudden cardiac death. The typical ECG pattern of ST-segment ... WebFlecainide is an antiarrhythmic. It works by blocking sodium channels, which play a major part in your heart's electrical activity. When your heart is firing too quickly in an abnormal rhythm (arrhythmia), flecainide slows … eagle watch golf lexington ky
Twenty-five years in the making: flecainide is safe and effective …
WebMar 1, 2024 · Congestive heart failure (severe) or. Heart disease (e.g., cardiomyopathy) or. Sick sinus syndrome (type of abnormal heart rhythm)—Use with caution. May make these conditions worse. Electrolyte imbalance (e.g., high or low potassium in the blood)—Should be corrected first before using this medicine. Kidney disease or. WebJan 5, 2024 · Flecainide may cause serious side effects. Call your doctor at once if you have: fast or pounding heartbeats; fluttering in your chest, shortness of breath, and sudden dizziness (like you might pass out); slow heart rate, weak pulse, slow breathing (breathing may stop); feeling short of breath; swelling, rapid weight gain; WebAug 1, 2011 · ECG taken when the patient was not using flecainide. His PAF was not rapid and did not cause hemodynamic or ischemic symptoms. During 2003 to 2004, the PAF … csn reaction